PHOENIX, Ariz., Feb. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", )), a pioneer in humane rodent pest control solutions, is pleased to announce the shipment of a substantial order of its Evolve™ Rodent Birth Control product to one of the largest warehousing and distribution companies in the Midwest. This marks SenesTech's entry into the warehousing and distribution sector, with the unnamed customer planning to implement Evolve Rodent Birth Control™ within their own facilities and distribute it through their extensive network. The warehousing industry i

PHOENIX, Feb. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", )), a pioneer in humane rodent pest control solutions, is pleased to announce that its Evolve™ Rodent Birth Control product line is now available for purchase on TractorSupply.com. This expansion represents another key milestone in SenesTech's e-commerce growth strategy, bringing its innovative and effective rodent control solution to a broader customer base nationwide. Tractor Supply Company is the largest rural lifestyle retailer in the United States, operating over 2,200 stores across 49 sta

PHOENIX, Feb. 4, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in humane pest control solutions, is pleased to announce its plans to enter the Indian rodent pest control market through a partnership with SMark, a well-established distributor based in India. The partnership is cemented by a recently signed letter of intent, underscoring the shared commitment to bringing innovative, non-lethal rodent control solutions to this rapidly growing market. India presents a significant opportunity for rodent pest control solutions, with an estimated market size exceeding

Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats PHOENIX, Jan. 21, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun integrating Evolve™, SenesTech's cutting-edge rodent birth control product, into the city's rodent management programs. This marks a pivotal step in Baltimore's efforts to address its significant rodent population, a challenge highlighted by a recent ranking of Baltimore as one of America's "rattiest cities." The city has placed a substantial initial order for Evolve and plans to deploy the product this quarter as part of it

PHOENIX, Jan. 14, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a pioneer in humane pest control solutions, is pleased to announce that Evolve™ Rodent Birth Control, our innovative rodent control product, will soon be available through Bug Off Pest Control in New York City. In addition to distribution, Bug Off will be marketing and selling Evolve throughout its network and providing ongoing training to pest management professionals (PMPs) in the Greater New York area. "Bug Off and Andy Linares, President of Bug Off, are well known an

PHOENIX, Jan. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a pioneer in humane pest control solutions, is pleased to announce that Joshua M. Moss will be joining the Board of Directors of SenesTech, Inc. Joshua M. Moss is the co-founder, Managing Director, and Portfolio Manager at EAM Global Investors, a boutique investment firm specializing in non-U.S. and emerging market equities with approximately $3 billion in assets under management. With over 20 years of experience in institutional investment management, Josh has a proven

Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.Gross margin percentages improved to 65% during Q3 2024 compared to

Significantly Expanding Market Reach PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in fertility control solutions for managing animal pest populations, is excited to announce a significant expansion in the distribution of its groundbreaking rodent birth control product. Evolve™ Rat and Evolve™ Mouse are now available on Walmart Marketplace, one of the largest and most trusted eCommerce platforms in the world. SenesTech developed its proprietary technology for managing rat and mouse populations—through fert

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results. Third Quarter 2024 Conference Call Details Date and Time: Tuesday, November 12, 2024, at 5:00 pm ET Call-in Information: Interested parties can access th

PHOENIX, Oct. 31, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in birth control to manage rodent pest populations, today announces the successful registration of Evolve™ in Hong Kong. A Sustainable and Humane Approach to Rodent Control Hong Kong welcomes Evolve™, an innovative, non-lethal rodent birth control solution designed to target rat infestations at their root. Unlike conventional methods, Evolve restricts rodent reproduction, offering an effective and humane way to manage infestations without posing risks to humans, pets, wildlife, or the environment.

SCHEDULE 13G/A - SenesTech, Inc. (0001680378) (Subject)

8-K - SenesTech, Inc. (0001680378) (Filer)

10-Q - SenesTech, Inc. (0001680378) (Filer)

8-K - SenesTech, Inc. (0001680378) (Filer)

EFFECT - SenesTech, Inc. (0001680378) (Filer)

424B3 - SenesTech, Inc. (0001680378) (Filer)

S-3 - SenesTech, Inc. (0001680378) (Filer)

D - SenesTech, Inc. (0001680378) (Filer)

8-K - SenesTech, Inc. (0001680378) (Filer)

10-Q - SenesTech, Inc. (0001680378) (Filer)

4 - SenesTech, Inc. (0001680378) (Issuer)

3 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.Gross margin percentages improved to 65% during Q3 2024 compared to

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results. Third Quarter 2024 Conference Call Details Date and Time: Tuesday, November 12, 2024, at 5:00 pm ET Call-in Information: Interested parties can access th

Record Revenue and Margin Performance PHOENIX, Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.Gross margin percentages improved to 54% during Q2 2024 compared to 47% in Q1 2024

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results. Second Quarter 2024 Conference Call Details Date and Time: Thursday, August 8, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the confere

PHOENIX, May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024. Recent Highlights Record quarterly revenues during Q1 2024 of $415,000, an increase of 78% compared to Q1 2023.Evolve™, formulated especially for the control of rat fertility and launched at the beginning of the year, has quickly become the Company'

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its first quarter 2024, ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results. First Quarter 2024 Conference Call Details Date and Time: Thursday, May 9, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the conference call by

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Feb. 15, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its fourth quarter and fiscal year 2023, ended December 31, 2023, after the market close on Wednesday, February 21, 2024. The Company has scheduled a conference call that same day, Wednesday, February 21, 2024, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2023 Conference Call Details Date and Time: Wednesday, February 21, 2024, at 5:00 pm ET Call-in Infor

July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Aug. 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023. "We successfully executed against a number of key strategic imperatives to drive long-term growth in Co

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 3, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on Thursday, August 10, 2023. The Company has scheduled a conference call that same day, Thursday, August 10, 2023, at 5:00 pm ET, to review the results. Second Quarter 2023 Conference Call Details Date and Time: Thursday, August 10, 2023, at 5:00 pm ET Call-in Information: Interested parties can access the conf

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 4, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023. The Company has scheduled a conference call that same day, Thursday, May 11, 2023, at 5:00 pm ET, to review the results. First Quarter 2023 Conference Call Details Date and Time: Thursday, May 11, 2023, at 5:00 pm ET Call-in Information: Interested parties can access the conference call

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)